Evidence map›Paper›PMID 41196929›Full record

ArticleArchives of endocrinology and metabolism2025

Position statement on macroprolactinemia from the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC/ML).

Andrea Glezer, Paula Condé Lamparelli Elias, Vania Dos Santos Nunes Nogueira, Heraldo Mendes Garmes, Leandro Kasuki, Guilherme Alcides Flôres Soares Rollin, Manoel Ricardo Alves Martins, Adriana Caschera Leme, Pedro Saddi Rosa, Luciana Ansaneli Naves and 1 more

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Andrea GlezerUnidade de Neuroendocrinologia, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brasil.
Paula Condé Lamparelli EliasDepartamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil.
Vania Dos Santos Nunes NogueiraUniversidade Estadual Paulista, Faculdade de Medicina, São Paulo, SP, Brasil.
Heraldo Mendes GarmesDisciplina de Endocrinologia e Metabologia, Departamento de Clínica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, SP, Brasil.
Leandro KasukiCentro de Pesquisa em Neuroendocrinologia, Hospital Universitário Clementino Fraga Filho/Universidade Federal do Rio de Janeiro e Unidade de Neuroendócrina do Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, RJ, Brasil.
Guilherme Alcides Flôres Soares RollinServiço de Endocrinologia e Nutrologia, Hospital Moinhos de Vento, Porto Alegre, RS, Brasil.
Manoel Ricardo Alves MartinsDepartamento de Medicina Clínica e Núcleo de Pesquisa e Desenvolvimento de Medicamentos, Universidade Federal do Ceará, Fortaleza, CE, Brasil.
Adriana Caschera LemeLaboratório Clínico, Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.
Pedro Saddi RosaFleury Medicina e Saúde, São Paulo, SP, Brasil.
Luciana Ansaneli NavesServiço de Endocrinologia, Hospital Universitário, Universidade de Brasília, DF, Brasil Grupo Sabin, Brasília, DF, Brasil.
Marcelo Cidade BatistaLaboratório Clínico, Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Measurement of serum prolactin levels is a common practice in clinical settings, particularly among women of reproductive age. In cases of hyperprolactinemia, identifying macroprolactinemia can help prevent unnecessary investigation and inappropriate treatments. This Position Statement, jointly prepared by the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC/ML), addresses several aspects of macroprolactinemia relevant to clinical practice - including concepts, definitions, epidemiological aspects, measurement techniques, and the role of screening - and discusses some clinical dilemmas.

Indexed as

HyperprolactinemiaProlactinBrazilEndocrinologyFemaleHumansNeuroendocrinologySocieties, MedicalProlactin

Identifiers

PMID41196929
PMCPMC12599139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.